Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
5,460
Views
6
CrossRef citations to date
0
Altmetric
Dermatology
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective
Katja C. HeinzDepartment of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The NetherlandsCorrespondence[email protected]
, Damon WillemsDepartment of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
https://orcid.org/0000-0001-8263-4047
Mickaël HiligsmannDepartment of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
https://orcid.org/0000-0003-4274-9258
Pages 491-502
|
Received 07 Jan 2022, Accepted 25 Mar 2022, Published online: 09 Apr 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.